Literature DB >> 8384745

Absence of mutation in the p53 and the retinoblastoma susceptibility genes in primary cervical carcinomas.

K B Choo1, K Y Chong.   

Abstract

Previous biochemical and structural studies using established cell lines have led to a hypothesis that the cellular p53 and the retinoblastoma susceptibility (Rb) proteins may play a crucial role in the pathogenesis process of cervical carcinoma. To further test this hypothesis, we have analyzed the structure of the p53 and Rb genes in 38 primary cervical carcinoma samples with known HPV status using the polymerase chain reaction-based single-strand conformation polymorphism (SSCP) approach. All 11 exons as well as 500 bp of the 5'-noncoding region of the p53 gene and exons 13-23 of the Rb gene were analyzed. None of these exons in all the samples analyzed showed band shift in the SSCP gel indicative of the presence of mutation. In the same experiments, however, all known exon mutations as well as previously unreported mutations in the intron sequences of the p53 and Rb genes in the HPV-free C33-A and HT-3 cell lines were detected. The absence of mutation in the p53 gene in all five HPV-negative samples was confirmed by direct sequence analysis. It appears that p53 and Rb mutations are a very rare event in cervical cancer and their occurrence is apparently not strictly correlated with HPV status.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8384745     DOI: 10.1006/viro.1993.1224

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  9 in total

1.  Detection of human papillomavirus DNA and oncoprotein overexpression are associated with distinct morphological patterns of tonsillar squamous cell carcinoma.

Authors:  S P Wilczynski; B T Lin; Y Xie; I B Paz
Journal:  Am J Pathol       Date:  1998-01       Impact factor: 4.307

Review 2.  Aberrant cell cycle regulation in cervical carcinoma.

Authors:  Young Tae Kim; Min Zhao
Journal:  Yonsei Med J       Date:  2005-10-31       Impact factor: 2.759

3.  BK virus as a cofactor in the etiology of prostate cancer in its early stages.

Authors:  Dweepanita Das; Kirk Wojno; Michael J Imperiale
Journal:  J Virol       Date:  2007-12-26       Impact factor: 5.103

4.  Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions.

Authors:  T Sano; T Oyama; K Kashiwabara; T Fukuda; T Nakajima
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

5.  Changes in retinoblastoma gene expression during cervical cancer progression.

Authors:  Mauricio Salcedo; Lucía Taja; Dolores Utrera; Pedro Chávez; Alfredo Hidalgo; Carlos Pérez; Luis Benítez; Cristina Castañeda; Ricardo Delgado; Patricio Gariglio
Journal:  Int J Exp Pathol       Date:  2002-12       Impact factor: 1.925

6.  The naturally born fusariotoxin enniatin B and sorafenib exert synergistic activity against cervical cancer in vitro and in vivo.

Authors:  Rita Dornetshuber-Fleiss; Daniela Heilos; Thomas Mohr; Lennart Richter; Roderich D Süssmuth; Markus Zlesak; Astrid Novicky; Petra Heffeter; Rosa Lemmens-Gruber; Walter Berger
Journal:  Biochem Pharmacol       Date:  2014-12-31       Impact factor: 5.858

7.  A possible involvement of aberrant expression of the FHIT gene in the carcinogenesis of squamous cell carcinoma of the uterine cervix.

Authors:  S Nakagawa; H Yoshikawa; M Kimura; K Kawana; K Matsumoto; T Onda; N Kino; M Yamada; T Yasugi; Y Taketani
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

8.  Elderly Japanese women with cervical carcinoma show higher proportions of both intermediate-risk human papillomavirus types and p53 mutations.

Authors:  S Nakagawa; H Yoshikawa; H Jimbo; T Onda; T Yasugi; K Matsumoto; N Kino; K Kawana; T Kozuka; K Nakagawa; M Aoki; Y Taketani
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

9.  Mutations in the TP53 gene and protein expression of p53, MDM 2 and p21/WAF-1 in primary cervical carcinomas with no or low human papillomavirus load.

Authors:  A Helland; F Karlsen; E U Due; R Holm; G Kristensen; A l Børresen-Dale
Journal:  Br J Cancer       Date:  1998-07       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.